Azenta (NASDAQ:AZTA) Announces Quarterly Earnings Results, Beats Estimates By $0.17 EPS

Azenta (NASDAQ:AZTA) announced its earnings results on Tuesday. The company reported $0.28 EPS for the quarter, beating analysts’ consensus estimates of $0.11 by $0.17, FiscalAI reports. The company had revenue of $167.09 million during the quarter, compared to analysts’ expectations of $160.16 million. Azenta had a positive return on equity of 1.18% and a negative net margin of 20.63%.

Azenta Trading Up 17.7%

AZTA traded up $7.17 on Wednesday, hitting $47.65. 554,508 shares of the company were exchanged, compared to its average volume of 937,005. The firm has a 50-day moving average price of $35.64 and a two-hundred day moving average price of $28.47. Azenta has a twelve month low of $15.93 and a twelve month high of $48.50. The company has a market cap of $2.09 billion, a price-to-earnings ratio of -17.38 and a beta of 1.47.

Analyst Ratings Changes

Several brokerages have recently issued reports on AZTA. Needham & Company LLC reissued a “buy” rating and set a $37.00 price target on shares of Azenta in a research report on Monday, September 14th. Wall Street Zen cut shares of Azenta from a “buy” rating to a “hold” rating in a report on Sunday, October 18th. Finally, Weiss Ratings raised shares of Azenta from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Wednesday, August 26th. Four investment analysts have rated the stock with a Buy rating, two have given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of $41.20.

Trending Headlines about Azenta

Here are a few of the latest headlines about AZTA:

• Positive Sentiment: For fiscal Q4 2026, Azenta reported adjusted EPS of $0.28, versus analysts’ $0.11 estimate, and revenue of $167.09 million, above the $160.16 million consensus. Revenue grew 5% year over year as reported and 2% organically. Azenta Reports Fourth Quarter and Full Year Results for Fiscal 2026
• Positive Sentiment: Fiscal 2027 revenue guidance of $648 million to $660 million is above the $632.4 million consensus. Azenta also expects 3%–5% organic revenue growth and adjusted EBITDA margin expansion of about 200–250 basis points, signaling expectations for continued growth and improved profitability. Azenta Reports Fourth Quarter and Full Year Results for Fiscal 2026
• Negative Sentiment: Rosen Law Firm said it is investigating potential securities claims tied to allegations that Azenta may have provided materially misleading business information. The inquiry could create legal and reputational uncertainty, but the announcement describes allegations, not a finding of misconduct. Rosen Law Firm investigation announcement

About Azenta

Azenta, Inc. provides products and services for life sciences research and the management of biological samples. Its offerings include automated sample storage systems, laboratory automation equipment, consumables, and software used to track and manage samples. The company also provides genomic services through GENEWIZ, including sequencing and other genetic analysis services for researchers and organizations in the life sciences and pharmaceutical industries. Azenta was formed in 2021 when Brooks Automation separated its life sciences business and adopted the Azenta name.